Overview

A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron

Status:
Withdrawn
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This is a pilot study designed to compare the tolerance of ionic iron (ferrous sulphate) with heme iron polypeptide. Subjects will take one week of one product followed by a week with no product followed by a week with the other product. Subjects will complete a daily diary to assess side effects. Hypothesis: Heme iron polypeptide is associated with fewer gastrointestinal side effects than ionic iron.
Phase:
Phase 4
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Iron